Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.71 USD | -1.05% | +6.20% | -25.53% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.53% | 2.21B | |
+50.84% | 59.28B | |
+41.42% | 40.94B | |
-5.50% | 40.17B | |
-5.16% | 28.69B | |
+12.62% | 26.63B | |
-20.48% | 18.89B | |
+31.36% | 12.46B | |
+0.32% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Canaccord Genuity Adjusts Price Target on Intellia Therapeutics to $73 From $72, Maintains Buy Rating